EA201890898A1 - Новые соединения и конъюгаты криптофицина, их получение и их терапевтическое применение - Google Patents

Новые соединения и конъюгаты криптофицина, их получение и их терапевтическое применение

Info

Publication number
EA201890898A1
EA201890898A1 EA201890898A EA201890898A EA201890898A1 EA 201890898 A1 EA201890898 A1 EA 201890898A1 EA 201890898 A EA201890898 A EA 201890898A EA 201890898 A EA201890898 A EA 201890898A EA 201890898 A1 EA201890898 A1 EA 201890898A1
Authority
EA
Eurasian Patent Office
Prior art keywords
conjugates
cryptophicine
recovery
therapeutic application
new connections
Prior art date
Application number
EA201890898A
Other languages
English (en)
Other versions
EA035625B1 (ru
Inventor
Антони Биго
Эрве Бушар
Мари-Присцилл Брэн
Франсуа Клер
Цзидун Чжан
Original Assignee
Санофи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи filed Critical Санофи
Publication of EA201890898A1 publication Critical patent/EA201890898A1/ru
Publication of EA035625B1 publication Critical patent/EA035625B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к соединениям криптофицина формулы (I)Изобретение также относится к полезным нагрузкам криптофицина, к конъюгатам криптофицина, к композициям, содержащим их, и к их терапевтическому применению, в частности в качестве противоопухолевых средств. Изобретение также относится к способу получения данных конъюгатов.
EA201890898A 2015-11-05 2016-11-03 Новые соединения и конъюгаты криптофицина, их получение и их терапевтическое применение EA035625B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15306751 2015-11-05
PCT/EP2016/076603 WO2017076998A1 (en) 2015-11-05 2016-11-03 Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use

Publications (2)

Publication Number Publication Date
EA201890898A1 true EA201890898A1 (ru) 2018-10-31
EA035625B1 EA035625B1 (ru) 2020-07-17

Family

ID=54476881

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201890898A EA035625B1 (ru) 2015-11-05 2016-11-03 Новые соединения и конъюгаты криптофицина, их получение и их терапевтическое применение

Country Status (35)

Country Link
US (2) US10941139B2 (ru)
EP (1) EP3371179B1 (ru)
JP (1) JP6929292B2 (ru)
KR (1) KR20180073678A (ru)
CN (1) CN108349960B (ru)
AR (1) AR106604A1 (ru)
AU (1) AU2016347724B2 (ru)
CA (1) CA3003085A1 (ru)
CL (1) CL2018001210A1 (ru)
CO (1) CO2018004581A2 (ru)
CR (1) CR20180256A (ru)
CY (1) CY1122441T1 (ru)
DK (1) DK3371179T3 (ru)
EA (1) EA035625B1 (ru)
EC (1) ECSP18034035A (ru)
ES (1) ES2755101T3 (ru)
HK (1) HK1256754B (ru)
HR (1) HRP20191729T1 (ru)
HU (1) HUE046033T2 (ru)
IL (1) IL259067B (ru)
LT (1) LT3371179T (ru)
MA (1) MA43160B1 (ru)
MX (1) MX2018005379A (ru)
MY (1) MY189448A (ru)
PH (1) PH12018500852B1 (ru)
PL (1) PL3371179T3 (ru)
PT (1) PT3371179T (ru)
RS (1) RS59498B1 (ru)
SG (1) SG11201803181SA (ru)
SI (1) SI3371179T1 (ru)
TN (1) TN2018000131A1 (ru)
TW (1) TWI714661B (ru)
UY (1) UY36979A (ru)
WO (1) WO2017076998A1 (ru)
ZA (1) ZA201802322B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI714661B (zh) 2015-11-05 2021-01-01 法商賽諾菲公司 新穎念珠藻素化合物及接合物、其製備與其治療用途
CN107043380A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN110831633A (zh) * 2017-05-10 2020-02-21 赛诺菲 可用于治疗的肽类接头和念珠藻素缀合物及其制备
CN108107103B (zh) * 2017-12-14 2020-10-16 华中师范大学 谷氨酸受体的质谱探针及其在脑组织中的空间分布规律检测方法
CA3132613A1 (en) 2019-03-07 2020-09-10 Conatus Pharmaceuticals Inc. Caspase inhibitors and methods of use thereof
US11530204B2 (en) 2019-09-30 2022-12-20 The Regents Of The University Of Michigan Biocatalytic synthesis of cryptophycin anticancer agents
EP4046996A1 (en) 2021-02-19 2022-08-24 Universität Bielefeld Cryptophycin compounds and conjugates thereof
WO2023161291A1 (en) 2022-02-22 2023-08-31 Araris Biotech Ag Peptide linkers comprising two or more payloads

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017093A1 (en) * 1993-12-21 1995-06-29 University Of Hawaii New cryptophycins
US20020128185A1 (en) * 1998-02-25 2002-09-12 Chuan Shih Pharmaceutical compounds
US7230101B1 (en) 2002-08-28 2007-06-12 Gpc Biotech, Inc. Synthesis of methotrexate-containing heterodimeric molecules
US20050175619A1 (en) 2004-02-05 2005-08-11 Robert Duffy Methods of producing antibody conjugates
US8212083B2 (en) 2006-04-27 2012-07-03 Intezyne Technologies, Inc. Heterobifunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
EP2044122B1 (en) 2006-07-18 2018-03-28 Sanofi Antagonist antibody against epha2 for the treatment of cancer
FR2947269B1 (fr) * 2009-06-29 2013-01-18 Sanofi Aventis Nouveaux composes anticancereux
AR078470A1 (es) 2009-10-02 2011-11-09 Sanofi Aventis Anticuerpos que se unen especificamente al receptor epha2
TWI714661B (zh) 2015-11-05 2021-01-01 法商賽諾菲公司 新穎念珠藻素化合物及接合物、其製備與其治療用途

Also Published As

Publication number Publication date
AU2016347724B2 (en) 2021-04-01
IL259067B (en) 2021-07-29
CO2018004581A2 (es) 2018-07-19
PT3371179T (pt) 2019-11-18
TW201730164A (zh) 2017-09-01
HUE046033T2 (hu) 2020-01-28
SI3371179T1 (sl) 2019-11-29
MX2018005379A (es) 2018-09-05
NZ741734A (en) 2023-10-27
RS59498B1 (sr) 2019-12-31
TN2018000131A1 (en) 2019-10-04
MY189448A (en) 2022-02-14
EA035625B1 (ru) 2020-07-17
CL2018001210A1 (es) 2018-08-17
JP2018535255A (ja) 2018-11-29
PL3371179T3 (pl) 2020-02-28
CN108349960A (zh) 2018-07-31
US20190382391A1 (en) 2019-12-19
CY1122441T1 (el) 2021-01-27
HK1256754B (zh) 2020-06-05
CN108349960B (zh) 2022-05-27
CA3003085A1 (en) 2017-05-11
WO2017076998A1 (en) 2017-05-11
SG11201803181SA (en) 2018-05-30
EP3371179A1 (en) 2018-09-12
US10941139B2 (en) 2021-03-09
ZA201802322B (en) 2019-01-30
TWI714661B (zh) 2021-01-01
UY36979A (es) 2017-06-30
HRP20191729T1 (hr) 2019-12-13
LT3371179T (lt) 2019-11-11
US20210163458A1 (en) 2021-06-03
AR106604A1 (es) 2018-01-31
JP6929292B2 (ja) 2021-09-01
BR112018008490A2 (pt) 2019-02-12
DK3371179T3 (da) 2019-11-11
PH12018500852A1 (en) 2018-10-29
CR20180256A (es) 2018-08-13
EP3371179B1 (en) 2019-08-07
MA43160B1 (fr) 2019-12-31
PH12018500852B1 (en) 2018-10-29
KR20180073678A (ko) 2018-07-02
ECSP18034035A (es) 2018-05-31
ES2755101T3 (es) 2020-04-21
AU2016347724A1 (en) 2018-05-10
IL259067A (en) 2018-06-28

Similar Documents

Publication Publication Date Title
EA201890898A1 (ru) Новые соединения и конъюгаты криптофицина, их получение и их терапевтическое применение
EA201990240A1 (ru) Новые трициклические соединения в качестве противораковых средств
EA201891083A1 (ru) Составы антител к cd38 для подкожного введения и их применение
EA201691940A1 (ru) Новые соединения
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201591748A1 (ru) Модуляторы p2x7
EA201590534A1 (ru) Новые бициклические производные
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
TR201900360T4 (tr) Valsartan ve ahu-377 i̇çeren tri̇sodyum çok moleküllü kompleksi̇n kri̇stali̇n formlari ve bunun yöntemleri̇
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
EA202090098A1 (ru) Фармацевтические композиции терапевтически активных соединений
EA201591451A1 (ru) Модуляторы flap
EA201590887A1 (ru) Композиция
EA201790570A1 (ru) Модуляторы р2х7
EA201691141A1 (ru) Соединения против ccr6
EA201790496A1 (ru) Соединения 1-алкил-6-оксо-1,6-дигидропиридин-3-ила и применение в качестве модуляторов sgrm
EA201500931A1 (ru) Производные пиридин-4-ила
BR112017009289A2 (pt) métodos de administrar composições de amantadina
EA201791600A1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
EA201791432A1 (ru) Композиции на основе пролекарства монометилфумарата
EA201690561A1 (ru) Пептидилнитрильные соединения в качестве ингибиторов дипептидилпептидазы i

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM